EVOGENE LTD (EVGN)
IL0011050551 - Common Stock
The trading volume of these stocks is deviating from the norm in today's session.
The trading volume of these stocks is deviating from the norm in today's session.
Casterra Announces a Key Milestone in its Operational Expansion Plan in Africa, with Completion of First Shipment of Castor Seeds Grown and Processed in Kenya
/PRNewswire/ -- Casterra Ag Ltd. ("Casterra"), an integrated castor cultivation solution company for oil production for bio-based products and biofuel, and a...
Lavie Bio Receives Grant from Israel Innovation Authority to Advance the Development of 'MicroFermentor', a Unique Technology that Can Change the Economics of Ag-Biologicals
/PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company and a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), announced receiving a grant from...
Evogene Announces Pricing of US$5.5 Million Registered Direct Offering and Concurrent Private Placement
/PRNewswire/ -- Evogene Ltd. ("Evogene" or the "Company") (Nasdaq: EVGN, TASE: EVGN), a leading computational biology company aiming to revolutionize...
EVGN Stock Earnings: Evogene Misses EPS, Beats Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Evogene (NASDAQ:EVGN) just reported results for the second quarter of 2024.Evog...
EVGN Stock Earnings: Evogene Misses EPS, Beats Revenue for Q2 2024
EVGN stock results show that Evogene missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Evogene Reports Second Quarter 2024 Financial Results
Conference call and webcast: today, August 22, 2024, 9:00 am ET Financial and Business Highlights: H1 2024 revenues $5.1M, up from $1.3M in H1 2023; Q2 2024...
Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) (the "Company", "Evogene"), a leading computational biology company targeting to revolutionize...
Evogene Schedules Second Quarter 2024 Financial Results Release
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and...
Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) (the "Company" or "Evogene"), a leading computational biology company targeting to revolutionize...
Lavie Bio Announces Commercial Expansion of Yalos™ to Winter Wheat
/PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company and a subsidiary of Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), is pleased to announce the...
Casterra Announces an Additional Purchase Order to Supply Castor Seeds to a New African Country
/PRNewswire/ -- Casterra Ag Ltd., a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), is a provider of an integrated solution for industrial-scale...
EVGN Stock Earnings: Evogene Beats EPS, Beats Revenue for Q1 2024
EVGN stock results show that Evogene beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma
/PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd....
Evogene Reports First Quarter 2024 Financial Results
Conference call and webcast: today, May 23, 2024, 9:00 am ET Financial and Business Highlights: Q1 2024 revenue: $4.2M vs. $0.6M in Q1 2023; anticipating...
Casterra Announces Additional Agreements with Seed Producers to Meet Existing & Growing Demand for its Elite Castor Seeds
/PRNewswire/ -- Casterra Ag Ltd., an integrated solutions company for growing castor for bio-based industrial applications, such as biofuels & biopolymers and...
Evogene Schedules First Quarter 2024 Financial Results Release
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and...
Biomica to Present at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting
/PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd....
Biomica to Present at Digestive Disease Week (DDW) Conference 2024 Annual Meeting
/PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd....
Evogene and The Kitchen FoodTech Hub by Strauss Group Established Finally Foods Ltd. - Revolutionizing Protein Production in Plants for the Food Industry
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science-based product...
Evogene Announces Filing of Annual Report on Form 20-F
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science-based product...
Bayer AG and Lavie Bio Continue for Second Year of Biofungicides Validation Following Successful Lab and Greenhouse Testing
/PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company that develops microbiome-based, computational-driven bio-stimulant and bio-pesticide novel...
EVGN Stock Earnings: Evogene Beats EPS, Misses Revenue for Q4 2023
EVGN stock results show that Evogene beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
EVGN Stock Earnings: Evogene Beats EPS, Misses Revenue for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Evogene (NASDAQ:EVGN) just reported results for the fourth quarter of 2023.Evog...
Evogene Reports Fourth Quarter and Full Year 2023 Financial Results
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science-based product...
AgPlenus Achieves Milestone in Collaboration with Corteva to Develop Novel Herbicides
/PRNewswire/ -- AgPlenus Ltd., a global leader in designing and developing novel sustainable crop protection products and a subsidiary of Evogene Ltd. (Nasdaq:...
Evogene files for $200M mixed shelf offering (NASDAQ:EVGN)
Evogene files prospectus for $200M mixed shelf offering, clarifying it is not an offer to sell securities.
Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements
/PRNewswire/ -- Lavie Bio Ltd., a leading ag-biologicals company that develops microbiome-based, computational-driven bio-stimulant and bio-pesticide novel...
Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product discovery and...
AgPlenus Announces Appointment of Dr. Dan Jacob Gelvan as its Incoming Chief Executive Officer
/PRNewswire/ -- AgPlenus Ltd, a global leader in designing and developing novel sustainable crop protection products, and a subsidiary of Evogene Ltd. (Nasdaq:...
AgPlenus Announces Licensing & Collaboration Agreement with Bayer to Develop a New Sustainable Weed Control Solution
/PRNewswire/ -- AgPlenus Ltd., a global leader in designing and developing novel sustainable crop protection products and a subsidiary of Evogene Ltd. (Nasdaq:...
Evogene and Verb Biotics collaborate to advance probiotic innovation (NASDAQ:EVGN)
Evogene and Verb Biotics partner to develop probiotic bacteria that produce metabolites improving human health.
Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation
/PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product development...
Biomica CEO Set to Engage in Panel Discussion at 8th Annual European Microbiome Movement Summit
/PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd....
Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug
/PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd....
Biomica CEO Set to Attend JP Morgan Healthcare Week in San Francisco, January 8-11, 2024
/PRNewswire/ -- Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd....